Diabetic Retinopathy: From Molecular Mechanisms to Therapeutic Approach
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (31 March 2025) | Viewed by 1694
Special Issue Editor
Special Issue Information
Dear Colleagues,
As you know, Diabetic retinopathy (DR) is the leading cause of blindness in adults, caused by complex pathophysiology involving both vascular and neural components. Traditional treatments, including anti-VEGF agents and laser therapy, primarily focus on advanced stages of DR, yet limitations in treatment outcomes have also been reported. Therefore, this Special Issue aims to offer insights into disease progression prior to overt vascular damage by featuring the latest molecular mechanisms on the pathogenesis of DR, particularly early neurovascular and cellular mechanisms that have recently gained attention for their significance. By enhancing our understanding of retinal neurodegeneration and neurovascular unit dysfunction, we aim to contribute to the development of novel biomarkers, preventive strategies, and personalized therapeutic approaches that can greatly aid in DR management on the level of molecular research. This special issue thus seeks to bridge the gaps in current therapeutic approaches through a deeper understanding of DR. We welcome various submission types, including original research articles, and comprehensive reviews.
Dr. Heuiran Lee
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- retinal neurodegeneration
- diabetic retinopathy
- diabetic retinopathy (DR) Pathogenesis
- neurovascular unit (NVU) dysfunction
- biomarkers in diabetic retinopathy
- novel treatments for diabetic retinopathy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
